Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MyLiver: EC-MPS vs MMF in Liver Transplant
NCT00405652Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mycophenolate sodium in Liver transplant rejection, sponsored by Novartis. Primary endpoint: Changes in Gastrointestinal Symptom Severity and Health Related Quality of Life. Started Jan 2007; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00405652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405652.